Born from Dr. Kichul Cha’s effort to make bioimpedance measurements clinically dependable, InBody has grown from a South Korean startup founded in 1996 into a medical technology company serving clinicians and researchers worldwide. InBody BWA, established in Pennsylvania in 2023, is the group’s medical division, focused on improving care for critically ill patients through more precise body-water analysis.
FDA Approved
FDA
Quality certification